Sunday 17 May 2020
Due to the current Covid-19 outbreak most events for 2021 have been postponed or cancelled. myNEO will attend job fairs and participate in the fol…
read more
Tuesday 12 January 2021
Multiple reports have revealed that the original strains of SARS-CoV-2 have been divergently mutating into different sub-strains with different chara…
Wednesday 4 November 2020
Ghent, Belgium, 4 November 2020 – myNEO, a developer of personalised therapeutics using the patient’s tumour-specific alterations, today announced th…
Monday 12 October 2020
myNEO has been selected as one of the five laureates for Belgian scale-up of the year (entrepreneurs on their way to an international breaktrough). …
Monday 7 September 2020
Cedric Bogaert will present the myNEO technology this week at the MedInvest – AI, Big Data and Digital Health conference. He will explain how AI can …
Monday 31 August 2020
myNEO recently affiliated with Amazon via the Amazon AWS activate program, that allows rapidly growing companies to further expand their MVP. This…
Thursday 2 July 2020
myNEO announces that promising Covid-19 peptides have been identified which will undergo further preclinical testing. By making smart use of existing…
Monday 18 May 2020
myNEO and eTheRNA announce a research programme to investigate a promising long non-coding RNA as a source of immunogenic targets for therapeutic use…
Monday 11 May 2020
myNEO collaborates with VUB-LMCT to develop high-throughput assays for immunogenicity validation of predicted SARS-CoV-2 epitopes The aim of the p…
Monday 4 May 2020
Over the last month, we’ve welcomed both Willem Stock, as a bioinformatician, Christophe Van Huffel, as busdev manager, and Bert Coessens, as technol…